Back to HomeBeta

ICD-10 Coding for Cervical Adenocarcinoma(C53.0, D06)

Complete ICD-10-CM coding and documentation guide for Cervical Adenocarcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Endocervical AdenocarcinomaCervical Glandular Cancer

Related ICD-10 Code Ranges

Complete code families applicable to Cervical Adenocarcinoma

C53-C53.9Primary Range

Malignant neoplasms of cervix uteri

This range includes all malignant neoplasms of the cervix, including adenocarcinoma.

Carcinoma in situ of cervix uteri

This range is used for adenocarcinoma in situ cases.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C53.0Malignant neoplasm of endocervixUse when adenocarcinoma is confirmed to originate from the endocervix.
  • Biopsy confirming adenocarcinoma
  • HPV testing positive for high-risk types
  • Imaging showing invasive characteristics
D06Carcinoma in situ of cervix uteriUse when adenocarcinoma is confined to the epithelial layer without invasion.
  • Histological confirmation of in situ carcinoma
  • No evidence of stromal invasion

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for cervical adenocarcinoma

Essential facts and insights about Cervical Adenocarcinoma

The ICD-10 code for cervical adenocarcinoma is C53.0 for invasive cases and D06 for in situ cases.

Primary ICD-10-CM Codes for cervical adenocarcinoma

Malignant neoplasm of endocervix
Billable Code

Decision Criteria

clinical Criteria

  • Confirmed adenocarcinoma from endocervical biopsy

coding Criteria

  • Use C53.0 for invasive adenocarcinoma of endocervix

documentation Criteria

  • Document tumor size, depth of invasion, and margins

Applicable To

  • Invasive adenocarcinoma of the cervical canal

Excludes

  • Carcinoma in situ of cervix (D06.-)

Clinical Validation Requirements

  • Biopsy confirming adenocarcinoma
  • HPV testing positive for high-risk types
  • Imaging showing invasive characteristics

Code-Specific Risks

  • Confusing with squamous cell carcinoma
  • Incorrectly coding as in situ

Coding Notes

  • Ensure documentation specifies 'endocervix' to avoid coding errors.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of malignant neoplasm of cervix uteri

Z85.43
Use for surveillance after treatment.

Secondary malignant neoplasm of bone

C79.51
Use when there is bone metastasis.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant neoplasm of endometrium

C54.1
Differentiate based on biopsy localization and imaging.

Malignant neoplasm of ovary, unspecified

C56.9
Exclude via imaging and tumor markers (CA-125).

Malignant neoplasm of endocervix

C53.0
Presence of stromal invasion differentiates from in situ.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Cervical Adenocarcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C53.0.

Impact

Clinical: May affect treatment options and prognosis., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims due to incomplete documentation.

Mitigation Strategy

Ensure HPV testing is performed and results documented., Include HPV status in all relevant reports.

Impact

Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.

Mitigation Strategy

Ensure documentation specifies 'endocervix' for accurate coding.

Impact

Reimbursement: Potential underpayment due to incorrect severity coding., Compliance: Violation of coding standards., Data Quality: Misleading clinical data affecting treatment decisions.

Mitigation Strategy

Verify depth of invasion in pathology reports to ensure correct coding.

Impact

Failure to document complete staging information can lead to coding errors.

Mitigation Strategy

Implement standardized templates for staging documentation.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Cervical Adenocarcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Cervical Adenocarcinoma

Use these documentation templates to ensure complete and accurate documentation for Cervical Adenocarcinoma. These templates include all required elements for proper coding and billing.

Initial diagnosis of cervical adenocarcinoma

Specialty: Gynecologic Oncology

Required Elements

  • Tumor site and size
  • Histologic type and grade
  • Depth of invasion
  • Lymphovascular invasion status
  • Margins and staging

Examples: Poor vs. Good Documentation

Poor Documentation Example
Adenocarcinoma of cervix.
Good Documentation Example
HPV-associated endocervical adenocarcinoma, usual type. FIGO stage IB1 (pT1b1N0M0). Tumor size: 2.5 cm. Depth of invasion: 8 mm. Lymphovascular invasion present. Margins negative.
Explanation
The good example provides specific details on tumor characteristics, staging, and margins, which are essential for accurate coding and treatment planning.

Need help with ICD-10 coding for Cervical Adenocarcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more